These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29446717)

  • 1. Activators of Sirtuin-1 and their Involvement in Cardioprotection.
    Granchi C; Minutolo F
    Curr Med Chem; 2018; 25(34):4432-4456. PubMed ID: 29446717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives.
    Bononi G; Citi V; Lapillo M; Martelli A; Poli G; Tuccinardi T; Granchi C; Testai L; Calderone V; Minutolo F
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.
    Pacholec M; Bleasdale JE; Chrunyk B; Cunningham D; Flynn D; Garofalo RS; Griffith D; Griffor M; Loulakis P; Pabst B; Qiu X; Stockman B; Thanabal V; Varghese A; Ward J; Withka J; Ahn K
    J Biol Chem; 2010 Mar; 285(11):8340-51. PubMed ID: 20061378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical effects of SIRT1 activators.
    Baur JA
    Biochim Biophys Acta; 2010 Aug; 1804(8):1626-34. PubMed ID: 19897059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How much successful are the medicinal chemists in modulation of SIRT1: A critical review.
    Kumar A; Chauhan S
    Eur J Med Chem; 2016 Aug; 119():45-69. PubMed ID: 27153347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Cellular Characterization of SIRT1 Allosteric Activators.
    Schultz MB; Rinaldi C; Lu Y; Amorim JA; Sinclair DA
    Methods Mol Biol; 2019; 1983():133-149. PubMed ID: 31087296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol.
    Cao D; Wang M; Qiu X; Liu D; Jiang H; Yang N; Xu RM
    Genes Dev; 2015 Jun; 29(12):1316-25. PubMed ID: 26109052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiscale landscape of molecular mechanism of SIRT1 activation by STACs.
    Liu F; Yang N
    Phys Chem Chem Phys; 2020 Jan; 22(2):826-837. PubMed ID: 31840716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a common mechanism of SIRT1 regulation by allosteric activators.
    Hubbard BP; Gomes AP; Dai H; Li J; Case AW; Considine T; Riera TV; Lee JE; E SY; Lamming DW; Pentelute BL; Schuman ER; Stevens LA; Ling AJ; Armour SM; Michan S; Zhao H; Jiang Y; Sweitzer SM; Blum CA; Disch JS; Ng PY; Howitz KT; Rolo AP; Hamuro Y; Moss J; Perni RB; Ellis JL; Vlasuk GP; Sinclair DA
    Science; 2013 Mar; 339(6124):1216-9. PubMed ID: 23471411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Assay of SIRT1-Activating Compounds.
    Dai H; Ellis JL; Sinclair DA; Hubbard BP
    Methods Enzymol; 2016; 574():213-244. PubMed ID: 27423864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183.
    Huber JL; McBurney MW; Distefano PS; McDonagh T
    Future Med Chem; 2010 Dec; 2(12):1751-9. PubMed ID: 21428798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Sirtuin 1 signaling pathway by ginsenosides.
    Lou T; Huang Q; Su H; Zhao D; Li X
    J Ethnopharmacol; 2021 Mar; 268():113657. PubMed ID: 33276056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases.
    Pillarisetti S
    Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):156-64. PubMed ID: 18991791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator.
    Dai H; Kustigian L; Carney D; Case A; Considine T; Hubbard BP; Perni RB; Riera TV; Szczepankiewicz B; Vlasuk GP; Stein RL
    J Biol Chem; 2010 Oct; 285(43):32695-32703. PubMed ID: 20702418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo.
    Smith JJ; Kenney RD; Gagne DJ; Frushour BP; Ladd W; Galonek HL; Israelian K; Song J; Razvadauskaite G; Lynch AV; Carney DP; Johnson RJ; Lavu S; Iffland A; Elliott PJ; Lambert PD; Elliston KO; Jirousek MR; Milne JC; Boss O
    BMC Syst Biol; 2009 Mar; 3():31. PubMed ID: 19284563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin 1: A Target for Kidney Diseases.
    Kong L; Wu H; Zhou W; Luo M; Tan Y; Miao L; Cai L
    Mol Med; 2015 Jan; 21(1):87-97. PubMed ID: 25587857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patent review of sirtuin activators: an update.
    Villalba JM; de Cabo R; Alcain FJ
    Expert Opin Ther Pat; 2012 Apr; 22(4):355-67. PubMed ID: 22475539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel SIRT1 activators endowed with cardioprotective profile.
    Flori L; Petrarolo G; Brogi S; La Motta C; Testai L; Calderone V
    Eur J Pharm Sci; 2021 Oct; 165():105930. PubMed ID: 34265406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.
    Milne JC; Lambert PD; Schenk S; Carney DP; Smith JJ; Gagne DJ; Jin L; Boss O; Perni RB; Vu CB; Bemis JE; Xie R; Disch JS; Ng PY; Nunes JJ; Lynch AV; Yang H; Galonek H; Israelian K; Choy W; Iffland A; Lavu S; Medvedik O; Sinclair DA; Olefsky JM; Jirousek MR; Elliott PJ; Westphal CH
    Nature; 2007 Nov; 450(7170):712-6. PubMed ID: 18046409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes.
    Höppner S; Delahaut P; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2014 Jan; 88():649-59. PubMed ID: 24239904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.